Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06924320 · ClinicalTrials.gov registry record · Phase 1

A Study of MET233 in Combination With MET097 in Individuals With Obesity or Overweight With or Without Diabetes

A Phase 1 study of Obesity and Obesity-related Medical Conditions, sponsored by Metsera, a wholly owned subsidiary of Pfizer.

Recruiting
Registry status
Phase 1
Development phase
132
Enrollment target
1
Study location

NCT06924320 is a Phase 1 study of Obesity and Obesity-related Medical Conditions that is actively recruiting participants, run by Metsera, a wholly owned subsidiary of Pfizer. The registered enrollment target is 132 participants, below the 527-participant average among 13 other Obesity and Obesity-related Medical Conditions trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06924320, a Phase 1 study of Obesity and Obesity-related Medical Conditions, is actively recruiting participants, sponsored by Metsera, a wholly owned subsidiary of Pfizer.

RECRUITING
Registry status
Phase 1
Development phase
132 participants
Enrollment target
1
Study location

Study Summary

This study is designed to test how well the combination of MET233 with MET097 works to treat individuals with obesity or overweight with or without diabetes.

Conditions Studied

Obesity and Obesity-related Medical Conditions

Interventions

  • DRUG Placebo
  • DRUG MET233 and MET097
  • DRUG MET233

Study Locations (1)

California

  • Research Site MET233/097 24-101-001 - Cypress

Trial Details

FieldValue
Enrollment Target 132 participants
Start Date 2025-03-03
Est. Completion 2027-03-15
Phase Phase 1

Sponsor

Metsera, a wholly owned subsidiary of Pfizer

7 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06924320

The ClinicalTrials.gov registry entry for NCT06924320 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 132 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 527-participant average among 13 other Obesity and Obesity-related Medical Conditions trials with a reported enrollment target (75% lower). The listed sponsor is Metsera, a wholly owned subsidiary of Pfizer, which has 7 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Obesity and Obesity-related Medical Conditions appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.

NCT06924320 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06924320 about?

NCT06924320 is a clinical study titled "A Study of MET233 in Combination With MET097 in Individuals With Obesity or Overweight With or Without Diabetes". This study is designed to test how well the combination of MET233 with MET097 works to treat individuals with obesity or overweight with or without diabetes.

What is the current status of trial NCT06924320?

This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 132 participants. The study started on 2025-03-03. Estimated completion is 2027-03-15.

What conditions does trial NCT06924320 study?

This clinical trial studies the following conditions: Obesity and Obesity-related Medical Conditions.

What interventions are being tested in trial NCT06924320?

The interventions under investigation include: Placebo (DRUG), MET233 and MET097 (DRUG), MET233 (DRUG).

Who is sponsoring clinical trial NCT06924320?

This trial is sponsored by Metsera, a wholly owned subsidiary of Pfizer, which has 7 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06924320 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Obesity and Obesity-related Medical Conditions

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Obesity and Obesity-related Medical Conditions

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.